federal_register: 00-23881
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 00-23881 | Medical Devices; CLIA Waiver Criteria; Public Workshop | Notice | The Food and Drug Administration (FDA) is extending to October 16, 2000, the comment period for the notice of a public workshop that appeared in the Federal Register of July 21, 2000 (65 FR 45384). That notice announced FDA's intention to review the criteria used to determine whether specific laboratory tests are waived from certain requirements of the Clinical Laboratory Improvement Amendments of 1988 (CLIA). This extension of the comment period is intended to allow interested persons additional time to submit comments on the CLIA waiver criteria. | 2000-09-15 | 2000 | 9 | https://www.federalregister.gov/documents/2000/09/15/00-23881/medical-devices-clia-waiver-criteria-public-workshop | https://www.govinfo.gov/content/pkg/FR-2000-09-15/pdf/00-23881.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) is extending to October 16, 2000, the comment period for the notice of a public workshop that appeared in the Federal Register of July 21, 2000 (65 FR 45384). That notice announced FDA's intention to review the... |